Table 3. Analysis of overall quality of life and domains among different subgroups of secreting vs. non-secreting tumors; microadenomas and macroadenomas vs. huge adenomas; with and without nasoseptal flap reconstruction.

		SNOT-22	Overall ASBS-Q score	Emotional state	Specific symptoms	Pain	Vitality	Physical function	Role of performance
Non-secreting tumors ( N  = 27)	Preop ( N  = 27)	17.12 ± 15.92	4.33 ± 0.62	4.07 ± 1.02	4.41 ± 0.55	4.21 ± 0.90	4.37 ± 0.69	4.51 ± 0.65	4.23 ± 0.80
	After 2 mo ( N  = 25)	17.72 ± 16.63	4.45 ± 0.60	4.37 ± 0.77	4.35 ± 0.73	4.20 ± 0.95	4.52 ± 0.64	4.59 ± 0.61	4.46 ± 0.61
	After 4–6 mo ( N  = 13)	14.63 ± 8.89	4.55 ± 0.42	4.40 ± 0.72	4.43 ± 0.55	4.62 ± 0.68	4.73  ± 0.30	4.63 ± 0.45	4.46 ± 0.55
Secreting tumors ( N  = 22)	Preop ( N  = 22)	20.90 ± 14.74	4.12 ± 0.68	3.63 ± 1.03	4.29 ± 0.59	3.94 ± 1.21	3.91 ± 1.12	4.44 ± 0.71	4.17 ± 0.78
	After 2 mo ( N  = 19)	13.69 ± 15.27	4.33 ± 0.68	4.23 ± 0.95	4.33 ± 0.59	4.39 ± 0.62	4.23 ± 1.02	4.47 ± 0.70	4.28 ± 0.80
	After 4–6 mo ( N  = 13)	24.50 ± 22.04	4.40 ± 0.55	4.03 ± 1.13	4.28 ± 0.74	4.38 ± 0.85	4.14  ± 0.94	4.80 ± 0.28	4.44 ± 0.41
Microadenomas and macroadenomas ( N  = 30)	Preop ( n  = 30)	19.29 ± 15.50	4.20 ± 0.68	3.83 ± 1.04	4.38 ± 0.59	3.98 ± 1.11	4.08 ± 1.05	4.43 ± 0.67	4.20 ± 0.76
	After 2 mo ( n  = 26)	14.00 ± 14.50	4.46 ± 0.59	4.43 ± 0.80	4.43 ± 0.56	4.41 ± 0.60	4.48 ± 0.86	4.55 ± 0.68	4.41 ± 0.70
	After 4–6 mo ( n  = 15)	20.13 ± 21.01	4.44 ± 0.57	4.13 ± 1.12	4.43 ± 0.73	4.36 ± 0.88	4.20 ± 0.93	4.79 ± 0.28	4.48 ± 0.45
Huge adenomas ( N  = 18)	Preop ( n  = 18)	18.12 ± 15.99	4.27 ± 0.64	3.89 ± 1.08	4.31 ± 0.55	4.22 ± 0.94	4.30 ± 0.70	4.53 ± 0.69	4.22 ± 0.85
	After 2 mo ( n  = 16)	19.18 ± 18.01	4.34 ± 0.69	4.13 ± 0.88	4.21 ± 0.82	4.06 ± 1.09	4.28 ± 0.74	4.54 ± 0.59	4.54 ± 0.59
	After 4–6 mo ( n  = 7)	16.75 ± 8.77	4.49 ± 0.40	4.35 ± 0.68	4.31 ± 0.56	4.64 ± 0.60	4.68 ± 0.30	4.58 ± 0.46	4.41 ± 0.54
No NSF reconstruction ( N  = 29)	Preop ( n  = 29)	17.36 ± 13.68	4.31 ± 0.55	3.94 ± 0.98	4.38 ± 0.52	4.13 ± 0.98	4.30 ± 0.65	4.53 ± 0.63	4.31 ± 0.59
	After 2 mo ( n  = 27)	12.92 ± 14.26	4.43 ± 0.53	4.38 ± 0.74	4.38 ± 0.52	4.20 ± 0.93	4.53 ± 0.51	4.56 ± 0.60	4.41 ± 0.61
	After 4–6 mo ( n  = 10)	20.73 ± 18.40	4.45 ± 0.55	3.96 ± 1.29	4.42 ± 0.51	4.30 ± 0.96	4.33 ± 0.97	4.82 ± 0.19	4.49 ± 0.46
With NSF reconstruction ( N  = 20)	Preop ( n  = 20)	21.17 ± 17.80	4.13 ± 0.78	3.78 ± 1.14	4.32 ± 0.64	4.03 ± 1.16	3.96 ± 1.21	4.40 ± 0.73	4.05 ± 1.00
	After 2 mo ( n  = 15)	21.73 ± 17.88	4.33 ± 0.78	4.20 ± 1.00	4.28 ± 0.90	4.42 ± 0.61	4.18 ± 1.17	4.53 ± 0.72	4.34 ± 0.83
	After 4–6 mo ( n  = 13)	19.37 ± 17.77	4.48 ± 0.46	4.38 ± 0.68	4.32 ± 0.73	4.63 ± 0.61	4.50 ± 0.59	4.64 ± 0.45	4.42 ± 0.50

Abbreviations: SNOT-22, Sinonasal Outcome Test 22; NSF, nasoseptal flap.